Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 9 Sep
Source: Bse
Financial Services stocks · Mid cap · NSE
Max Financial Services Limited (MFSL) is a holding company whose primary operating asset is Axis Max Life Insurance. It provides life insurance products across various categories including protection, savings, annuity, and ULIPs, distributed through proprietary and partnership channels.
full bear SMA stack · SMA20 -9.9% / mo · MACD − · near 52W low
Latest mapped FPI equity flow was not positive. View sector evidence
Adjusted completed-session prices, rebased to 100
Weak fundamentals, management trust needs verification, price trend argues for patience, and recent execution is weak.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue +16.8% · PAT +37.2% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
medium confidence · 3/6 claims checked
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Rev +17% YoY · PAT +37% YoY · +39% QoQ · operating leverage · margin compression
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹14,970 Cr | +16.8% | +38.6% |
| EBITDA | ₹167 Cr | +40.3% | +2883.3% |
| Operating margin | 1.1% | +20 bps | +120 bps |
| PAT | ₹118 Cr | +37.2% | NDF |
| PAT margin | 0.8% | +12 bps | +109 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 19/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Trend is weak — long-term trend down. RSI 33.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 11 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
Insurance economics depend on long-duration book value and new-business profitability.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +0 points.
Business-comparable peers in Financial Services — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
MFSL's consolidated revenue (ex-investment income) grew 17% YoY in FY26, with Axis Max Life Insurance reporting strong VNB growth of 26% and NBM expansion to 25.2%. Individual Adjusted First Year Premium rose 19%, outpacing private industry growth.
Axis Max Life Insurance demonstrated robust performance in FY26, with strong VNB growth, NBM expansion, and market share gains. Proprietary channels and specific product segments like Annuity and Retail Protection showed significant momentum, supporting the overall growth trajectory.
Latest issuer-disclosed distribution across 2 reported categories.
Proprietary channels APE grew by 28% on YoY basis driven by secular growth momentum within Offline and Online proprietary channels.
Annuity APE grew by 113% to Rs 1,050 cr during FY’26 vs Rs 492 cr during FY’25.
Retail Protection and Health APE grew by 53% to Rs 1,373 cr during FY’26 vs Rs 896 cr last year.
New partnership APE grew by 90% YoY during FY’26, contributing >5% of Individual APE.
VNB growth and NBM expansion driven by a balanced product mix and higher business volumes.
Focus is on selling longer term products along with improving penetration of pure protection & Health offerings.
Focus towards customer measures has helped deliver performance across health parameters and will continue to remain a priority.
Non-operating variance is Rs -714 cr in FY26.
Solvency ratio at 194% as of Mar’26, down from 201% in FY25.
Policyholder Expense to GWP Ratio increased to 14.6% in FY26 from 13.6% in FY25.
10% increase in mortality leads to a 3.1% decrease in EV and 7.2% decrease in VNB.
10% increase in expenses leads to a 0.9% decrease in EV and 9.1% decrease in VNB.
2% increase in corporate tax rate leads to a 2.4% decrease in EV and 3.5% decrease in VNB. Increase to 25% leads to 10.5% EV fall.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
The investor release provides annual financial performance for FY26, with comparisons explicitly stated on a Year-on-Year basis against FY25, making YoY the most relevant comparison for assessing long-term trends and growth.
MFSL revenue* excluding investment income at Rs 38,039 cr, grows 17% in FY’26.
Individual Adjusted first year Premium is at Rs 9,885 cr grew by 19% on YoY basis, ahead of the private industry which grew by 12% YoY.
Private Market share at 10.4% during FY’26 expanded by 56 bps from 9.8% during FY’25.
FY’26 VNB at Rs 2,647 cr grew by 26% YoY.
Axis Max Life has focused on ensuring growth in both its Proprietary and Bancassurance channels.
Launched Online Savings Plan Plus, Corporate Advantage in Retirement and Employee Benefit Smart Plan, and Group Smart Health Insurance Plan.
Protection and Retirement remains a key focus area for Axis Max life due to the long-term structural opportunity within the segment.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| New Business Margin (NBM) | 25.2% in FY26 | Sustained expansion or stability, indicating profitable growth and effective product mix management. |
| Proprietary Channels APE Growth | 28% YoY in FY26 | Continued outperformance relative to partnership channels, supporting margin bias. |
| Solvency Ratio | 194% as of Mar’26 | Maintenance above regulatory requirements and stability, indicating capital adequacy. |
| Policyholder Expense to GWP Ratio | 14.6% in FY26 | Trends in operational efficiency, as the ratio increased YoY. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Max Life aims for 3-4 times sales growth in protection and health.
"3-4x sales in 5 years"
Max Life aims for 3-4 times sales growth in protection and health.
"3-4x sales in 5 years"
Outcome check: Revenue YoY averaged 7.2% across 4 later quarter(s).
Max Life aims for approximately 8-9 times annuity sales growth.
"~8-9x annuity sales in 5 years"
Outcome check: Revenue YoY averaged 7.2% across 4 later quarter(s).
Max Life aims for approximately 8-9 times annuity sales growth.
"~8-9x annuity sales in 5 years"
Max Life aims for approximately 2.5 times sales growth in offline proprietary distribution.
"~2.5x sales in 5 years"
Max Life aims for approximately 2.5 times sales growth in offline proprietary distribution.
"~2.5x sales in 5 years"
Outcome check: Revenue YoY averaged 7.2% across 4 later quarter(s).
Max Life aims to be among the top 3 players in protection and health.
"Among top 3 players in protection and health"
Max Life aims to be among the top 3 players in protection and health.
"Among top 3 players in protection and health"
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Weak Trust: Management has 100% delivered/partly-delivered outcomes on 3 checked claims. It ranks around the 13th percentile of the scored universe and 21st percentile within Financial Services. Main check: financial discipline is weak at 10/100.
Mixed Trust: 3/6 extracted management claims have outcome checks; 0% were fully delivered and 3 were partially delivered.
Management or financial behaviour needs caution. Demand stronger valuation compensation.
overall median 67 · Financial Services: 21st pctile, median 62 · Mid: 6th pctile, median 76
3/6 claims checked. Use as directional, not final.
3/6 claims checked · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse